Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice.

UK-49,858 (fluconazole), a new, orally absorbed bis-triazole derivative, has been evaluated against systemic infections with Candida albicans in normal and immunosuppressed mice and against an intestinal infection with C. albicans in immunosuppressed mice. Orally administered ketoconazole was used a...

Full description

Bibliographic Details

Published in:	Antimicrob Agents Chemother
Main Authors:	Troke, P F, Andrews, R J, Brammer, K W, Marriott, M S, Richardson, K
Format:	Artigo
Language:	Inglês
Published:	American Society for Microbiology (ASM) 1985
Subjects:	Research Article
Online Access:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180335/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3002246/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.28.6.815
Tags:	Add Tag No Tags, Be the first to tag this record!